Richie Kohman, Synthetic Biology Platform Lead, Wyss Institute at Harvard, tells us all about Next Generation Sequencing in analysing synthetic biology signatures in brain tissue.
The WHO has renamed COVID variants of concern, as they believe that the scientific names can be "difficult" to use - leading to both misreporting and potential discrimination against countries of origin.
Steven Shepherd, Healthcare Director, SAS UK, explores how upgrades can be made in a way that is cost-efficient and where the NHS professionals asked to use those systems are comfortable with the upgrades.
Adapting their existing digital framework, SymlConnect address the severe outpatient waiting list backlog created by the impact of the COVID-19 pandemic, to enable secure patient-clinician remote communication.
Mike Sanders, Chief Executive Officer at Vital Hub UK Group of Companies, explains the importance of delivering sustainable solutions for healthcare in support of the whole patient journey beyond COVID-19.
New mathematical modelling from the University of Utah suggests that all severe COVID infections will disappear over the next ten years - if the global population has access to vaccination.
Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
